CannaRoyalty Corp., doing business as Origin House, is a Canada-based company. The Company is growing cannabis brands and distribution company in United States and Canada. The Company acts as a brand development platform by distribution, manufacturing, cultivation, and marketing services for it's clients. The Company is also developing infrastructure to support their customers.

Employees

Sector

Pharmaceuticals

More about the company

Delayed Canadian Securities Exchange			5-day change	1st Jan Change
- ^CAD	-.--%		-7.47%	-10.42%

21-03-29	Spyder Cannabis Inc. completed the acquisition of 180 Smoke LLC from Origin House for CAD 1.	CI
21-02-22	Spyder Cannabis Inc. entered into a binding agreement to acquire 180 Smoke LLC from Origin House.	CI

Market Cap	513M 443M 417M 379M 712M 49.07B 724M 4.88B 1.91B 24.57B 1.93B 1.89B 81.66B	P/E 2017	-17.4x	P/E 2018	-41.8x
Enterprise Value	460M 397M 373M 340M 639M 44B 649M 4.38B 1.71B 22.03B 1.73B 1.69B 73.22B	EV / Sales 2017	53,919,197x	EV / Sales 2018	19,487,976x
Free-Float	80.58%	Yield 2017 *	-	Yield 2018	-

21-03-29	Spyder Cannabis Inc. completed the acquisition of 180 Smoke LLC from Origin House for CAD 1.	CI
21-02-22	Spyder Cannabis Inc. entered into a binding agreement to acquire 180 Smoke LLC from Origin House.	CI
21-01-27	Driven Deliveries, Inc. cancelled the acquisition of Humboldt's Finest Farms.	CI
20-01-27	Driven Deliveries, Inc. signed a letter of intent to acquire Humboldt's Finest Farms.	CI
20-01-07	Cresco Labs Inc. (CNSX:CL) completed the acquisition of Origin House (CNSX:OH).	CI
19-12-30	Origin House Strengthens Partnership with Kings Garden Inc	CI
19-11-28	Tranche Update on Origin House's Equity Buyback Plan announced on August 9, 2018.	CI
19-11-25	Origin House announced that it has received CAD 39.599999 million in funding	CI
19-11-12	Origin House announced that it expects to receive CAD 39.599999 million in funding	CI
19-10-15	Origin House Announces Full Integration with California Cannabis Track-and-Trace System	CI
19-10-14	An unknown acquired Distribution and Manufacturing Facility in Sonoma County from Origin House (CNSX:OH) for $1.7 million.	CI
19-10-03	Cannaroyalty Corp. Signs Distribution Agreement with California Cannabis Infused Beverage Brand Cannabiniers	CI
19-10-03	Origin House Announces Executive Changes	CI

20-01-08	Origin House : Cresco Closes Acquisition of Origin House, Adding Leading California Wholesale Distribution and Cultivation Operations to Its Strategic National Footprint	BU
20-01-07	Origin House : Bhang and Origin House Mutually Terminate License Agreement	AQ
20-01-06	Origin House : Obtains Final Order for Proposed Arrangement with Cresco Labs Inc.	AQ
20-01-02	Origin House : Receives Shareholder Approval of Plan of Arrangement with Cresco Labs and Announces Extension and Addition of OCN Debt Facility	AQ
19-12-31	Origin House : Receives Shareholder Approval of Plan of Arrangement with Cresco Labs Inc. and Announces Extension and Addition of OCN Debt Facility	AQ

Origin House Stock

Stocks

OH

CA1376441004

Pharmaceuticals

Valuation: Origin House

Latest news : Origin House

Press Releases: Origin House

News in other languages: Origin House

Latest insider transactions

Alternative Medicine

Financials

Company Profile

Date	Insider	Type	Quantity	% Market Cap.
1/10/20	Marc Lustig	Other	1	0.0000%
1/10/20	Marc Lustig	Marche	171,335	0.2191%
1/10/20	Marc Lustig	Marche	1,879,825	2.4039%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ORIGIN HOUSE	-.--%	-7.47%	-	-	352M
YUNNAN BAIYAO GROUP CO.,LTD	-0.85%	-1.30%	-10.66%	-8.03%	13.35B
BEIJING TONGRENTANG CO., LTD	-1.45%	-1.41%	-32.69%	-56.83%	5.05B
DONG-E-E-JIAO CO., LTD.	-1.44%	-3.58%	+2.63%	+0.58%	4.98B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-0.82%	+4.31%	+5.02%	-30.41%	4.24B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-1.69%	-1.90%	-15.41%	-7.38%	3.65B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-1.96%	-9.52%	-8.48%	-2.27%	3.42B
TASLY PHARMACEUTICAL GROUP CO., LTD	-0.65%	-1.03%	-5.95%	+15.00%	3.42B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.56%	+3.11%	-14.19%	-15.51%	2.5B
ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.	+2.56%	+13.21%	+2.78%	-9.09%	1.76B
Average	-0.69%	-1.51%	-8.55%	-12.66%	4.27B
Weighted average by Cap.	-0.97%	-1.87%	-9.66%	-13.18%

	2017	2018
Net sales	3.08 2.66 2.5 2.27 4.27 294.32 4.34 29.27 11.44 147.39 11.56 11.31 489.79	18.69 16.15 15.17 13.8 25.94 1.79K 26.37 177.76 69.5 895.1 70.18 68.66 2.97K
Net income	-8.89M -7.68M -7.22M -6.56M -12.34M -850M -12.54M -84.56M -33.06M -426M -33.38M -32.66M -1.41B	-8.41M -7.27M -6.83M -6.21M -11.68M -805M -11.87M -80.01M -31.28M -403M -31.59M -30.9M -1.34B
Net Debt	-1.84M -1.59M -1.49M -1.36M -2.55M -176M -2.59M -17.49M -6.84M -88.05M -6.9M -6.75M -293M	-53.08M -45.84M -43.08M -39.18M -73.66M -5.08B -74.87M -505M -197M -2.54B -199M -195M -8.45B